Rubius Therapeutics Designing Pharmaceutical Facility in Smithfield, Rhode Island
10/04/2018
Once completed, the 135,000-square-foot facility will support 160 new, high-skilled jobs in manufacturing, biotech operations and other support functions. Rubius plans to invest up to $155 million over about five years to renovate an existing building in Smithfield.
Rubius Therapeutics is a biotech company that focuses on the development of lab-created red blood cells. Rubius genetically engineers cells to fight a wide range of diseases, including cancer and autoimmune diseases.
"Critical to Rubius Therapeutics' success in bringing our Red Cell Therapeutics to patients is the ability to manufacture large quantities of our treatments and to ensure these medicines are ready as soon as patients may need them," said Rubius Therapeutics CEO Dr. Pablo J. Cagnoni.
"The Rhode Island Commerce Corporation and Governor Raimondo have an impressive and growing track record of attracting top biotechnology companies and creating high paying jobs. I am happy to be able to say that Rubius Therapeutics is now a part of this booming ecosystem of biotechnology innovation,” he added.
In June, the Board of the Rhode Island Commerce Corporation approved tax credits through the Rebuild Rhode Island Tax Credit Program and the Qualified Jobs Incentive Act to support the project. Once construction is complete, Rubius will receive approximately $2.75 million in Rebuild Rhode Island Tax Credits. They were also approved to receive Qualified Jobs tax credits totaling approximately $370,000 per year over 10 years. The credits will only be paid out after the jobs are created and employees have paid income tax for a full year. Rubius will also be eligible for a sales tax rebate on construction materials.
"Thanks to our investments in economic development and skills training, Rhode Island's biotechnology industry is on the rise," said Governor Gina M. Raimondo. "Rubius is a leader in their field, and I'm thrilled that they're investing in our state and creating 160 good-paying jobs here in Smithfield."
"We are very pleased that Rubius Therapeutics has broken ground on its new advanced manufacturing facility," said R.I. Secretary of Commerce Stefan Pryor. "Rubius joins companies such as Amgen, Johnson & Johnson, and EpiVax in our flourishing bioscience ecosystem."
Project Announcements
Rapid Industries Expands Louisville, Kentucky, Operations
05/27/2022
Germany-Based Mühlbauer Expands Newport News, Virginia, Operations
05/27/2022
Manna Capital Partners-Ball Corporation Plan Valencia County, New Mexico, Aluminum Can Sheet Rolling Mill
05/27/2022
Merz North America Expands Sturtevant and Franksville, Wisconsin, Operations
05/26/2022
ATESTEO North America Plans East Lansing, Michigan, North American Headquarters
05/26/2022
Kroger Establishes Lockbourn, Ohio, Distribution Facility
05/26/2022
Most Read
-
The Evolution of the Megasite
Q2 2022
-
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Q1 2022
-
Rail Gains Advantage Amidst Supply Chain Snarls
Q2 2022
-
The 2021 Top States for Doing Business Reflect Their Locational Advantages
Q3 2021
-
Trends in Data Center Site Selection
Q2 2022
-
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2021
-
Innovative and Collaborative Design Sets the Stage for Life Science Innovation
Q2 2022